A RAPID REVIEW OF ECONOMIC EVALAUTIONS OF DONEPEZIL, RIVASTIGMINE, GALANTAMINE AND MEMANTINE FOR ALZHEIMER'S DISEASE (AD)

被引:0
|
作者
Feng, J. [1 ]
Huang, R. [1 ]
Pwee, K. [1 ]
机构
[1] Minist Hlth, Singapore, Singapore
关键词
D O I
10.1016/S1098-3015(11)73351-4
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A560 / A560
页数:1
相关论文
共 50 条
  • [1] The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease
    Loveman, E
    Green, C
    Kirby, J
    Takeda, A
    Picot, J
    Payne, E
    Clegg, A
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (01) : III - +
  • [2] Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Tan, Chen-Chen
    Yu, Jin-Tai
    Wang, Hui-Fu
    Tan, Meng-Shan
    Meng, Xiang-Fei
    Wang, Chong
    Jiang, Teng
    Zhu, Xi-Chen
    Tan, Lan
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 (02) : 615 - 631
  • [3] A Meta-Analysis of the Efficacy of Donepezil, Rivastigmine, Galantamine, and Memantine in Relation to Severity of Alzheimer's Disease
    Di Santo, Simona Gabriella
    Prinelli, Federica
    Adorni, Fulvio
    Caltagirone, Carlo
    Musicco, Massimo
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2013, 35 (02) : 349 - 361
  • [4] The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model
    Bond, M.
    Rogers, G.
    Peters, J.
    Anderson, R.
    Hoyle, M.
    Miners, A.
    Moxham, T.
    Davis, S.
    Thokala, P.
    Wailoo, A.
    Jeffreys, M.
    Hyde, C.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2012, 16 (21) : 1 - +
  • [6] Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease - A systematic review
    Clegg, A
    Bryant, J
    Nicholson, T
    McIntyre, L
    De Broe, S
    Gerard, K
    Waugh, N
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2002, 18 (03) : 497 - 507
  • [7] Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease
    Li, Dan-Dan
    Zhang, Ya-Hong
    Zhang, Wei
    Zhao, Pu
    [J]. FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [8] Memantine ER/Donepezil: A Review in Alzheimer's Disease
    Greig, Sarah L.
    [J]. CNS DRUGS, 2015, 29 (11) : 963 - 970
  • [9] Memantine ER/Donepezil: A Review in Alzheimer’s Disease
    Sarah L. Greig
    [J]. CNS Drugs, 2015, 29 : 963 - 970
  • [10] Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine
    Sicras-Mainar, A.
    Vergara, J.
    Leon-Colombo, T.
    Febrer, L.
    Rejas-Gutierrez, J.
    [J]. REVISTA DE NEUROLOGIA, 2006, 43 (08) : 449 - 453